Rhythm Pharmaceuticals (RYTM) Other Non-Current Assets (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Other Non-Current Assets of $601000.0 for Q1 2026, up 29.53% year-over-year from $464000.0 in Q1 2025, and up 15.13% quarter-over-quarter from $522000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Other Non-Current Assets (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 11 years of Other Non-Current Assets data on file, last reported at $601000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $601000.0, up 29.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $601000.0 (up 29.53% YoY), and the FY2025 annual result was $522000.0, up 12.5% from the prior year.
- Other Non-Current Assets climbed to $601000.0 in Q1 2026 per RYTM's latest filing, from $522000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $671000.0 in Q3 2025 and troughed at $328000.0 in Q1 2022.
- A 5-year average of $426764.7 and a median of $460000.0 in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets changed 0.0% in 2022, then surged 45.24% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $328000.0 in 2022, then changed by 0.0% to $328000.0 in 2023, then surged by 41.46% to $464000.0 in 2024, then grew by 12.5% to $522000.0 in 2025, then climbed by 15.13% to $601000.0 in 2026.
- Business Quant data shows RYTM's Other Non-Current Assets at $601000.0 in Q1 2026, $522000.0 in Q4 2025, and $671000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Rhythm Pharmaceuticals | 6.59 Bn | 6.25 Bn | 52.96 Mn | 601,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 601,000.00 |
| Dec 31, 2025 | 522,000.00 |
| Sep 30, 2025 | 671,000.00 |
| Jun 30, 2025 | 527,000.00 |
| Mar 31, 2025 | 464,000.00 |
| Dec 31, 2024 | 464,000.00 |
| Sep 30, 2024 | 462,000.00 |
| Jun 30, 2024 | 460,000.00 |
| Mar 31, 2024 | 460,000.00 |
| Dec 31, 2023 | 328,000.00 |
| Sep 30, 2023 | 328,000.00 |
| Jun 30, 2023 | 328,000.00 |
| Mar 31, 2023 | 328,000.00 |
| Dec 31, 2022 | 328,000.00 |
| Sep 30, 2022 | 328,000.00 |
| Jun 30, 2022 | 328,000.00 |
| Mar 31, 2022 | 328,000.00 |
| Dec 31, 2021 | 328,000.00 |
| Sep 30, 2021 | 328,000.00 |
| Jun 30, 2021 | 328,000.00 |